Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
Dallas Allergy Immunology Research
mi
from
Dallas, TX
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
Dallas Allergy Immunology Research
mi
from
Dallas, TX
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
University of Utah / Primary Children's Hospital
mi
from
Salt Lake City, UT
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
University of Utah / Primary Children's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
O&O Alpan
mi
from
Fairfax, VA
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
O&O Alpan
mi
from
Fairfax, VA
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
Bellingham Asthma, Allergy, & Immunology Clinic
mi
from
Bellingham, WA
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
Bellingham Asthma, Allergy, & Immunology Clinic
mi
from
Bellingham, WA
Click here to add this to my saved trials
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated:  5/11/2016
Egyesitett Szent Istvan es Szent Laszlo Korhaz
mi
from
Budapest,
Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases
Status: Enrolling
Updated: 5/11/2016
Egyesitett Szent Istvan es Szent Laszlo Korhaz
mi
from
Budapest,
Click here to add this to my saved trials
Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?
A Randomized Controlled Trial Showing the Effect of Patient Lenght of Stay in the Emergency Department Through Utilizing a Urinalysis Nursing Protocol.
Status: Enrolling
Updated:  5/12/2016
University of California Los Angeles Medical Center
mi
from
Los Angeles, CA
Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?
A Randomized Controlled Trial Showing the Effect of Patient Lenght of Stay in the Emergency Department Through Utilizing a Urinalysis Nursing Protocol.
Status: Enrolling
Updated: 5/12/2016
University of California Los Angeles Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.
Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.
Status: Enrolling
Updated:  5/12/2016
Truman Medical Center - Hospital Hill
mi
from
Kansas City, MO
Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.
Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.
Status: Enrolling
Updated: 5/12/2016
Truman Medical Center - Hospital Hill
mi
from
Kansas City, MO
Click here to add this to my saved trials
At-home Auditory Training Clinical Trial
At-home Auditory Training Clinical Trial
Status: Enrolling
Updated:  5/19/2016
IU Department of Speech & Hearing Sciences
mi
from
Bloomington, IN
At-home Auditory Training Clinical Trial
At-home Auditory Training Clinical Trial
Status: Enrolling
Updated: 5/19/2016
IU Department of Speech & Hearing Sciences
mi
from
Bloomington, IN
Click here to add this to my saved trials
Gulf War Illness Nasal Irrigation Study
Nasal Irrigation for Chronic Rhinosinusitis and Fatigue in Patients With Gulf War Illness
Status: Enrolling
Updated:  5/23/2016
University of Wisconsin General Clinical Research Center
mi
from
Madison, WI
Gulf War Illness Nasal Irrigation Study
Nasal Irrigation for Chronic Rhinosinusitis and Fatigue in Patients With Gulf War Illness
Status: Enrolling
Updated: 5/23/2016
University of Wisconsin General Clinical Research Center
mi
from
Madison, WI
Click here to add this to my saved trials
Calcitonin for Treating X-linked Hypophosphatemia
Calcitonin for Treating X-linked Hypophosphatemia
Status: Enrolling
Updated:  5/24/2016
Yale School of Medicine
mi
from
New Haven, CT
Calcitonin for Treating X-linked Hypophosphatemia
Calcitonin for Treating X-linked Hypophosphatemia
Status: Enrolling
Updated: 5/24/2016
Yale School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Transcranial Magnetic Stimulation for Tinnitus
Clinical Trial of Transcranial Magnetic Stimulation for Relief of Tinnitus
Status: Enrolling
Updated:  5/25/2016
VA Portland Health Care System, Portland, OR
mi
from
Portland, OR
Transcranial Magnetic Stimulation for Tinnitus
Clinical Trial of Transcranial Magnetic Stimulation for Relief of Tinnitus
Status: Enrolling
Updated: 5/25/2016
VA Portland Health Care System, Portland, OR
mi
from
Portland, OR
Click here to add this to my saved trials
Use of Radiographic Contrast to Detect Dental Caries
The Use of Radiographic Contrast to Differentiate Cavitated From Non-cavitated Dental Caries
Status: Enrolling
Updated:  5/31/2016
Creighton University School of Dentistry
mi
from
Omaha, NE
Use of Radiographic Contrast to Detect Dental Caries
The Use of Radiographic Contrast to Differentiate Cavitated From Non-cavitated Dental Caries
Status: Enrolling
Updated: 5/31/2016
Creighton University School of Dentistry
mi
from
Omaha, NE
Click here to add this to my saved trials
Fatigue Management in HIV
Fatigue Management in HIV: A Sleep and Circadian Rhythm Pilot Intervention
Status: Enrolling
Updated:  6/1/2016
University of California at San Francisco
mi
from
San Francisco, CA
Fatigue Management in HIV
Fatigue Management in HIV: A Sleep and Circadian Rhythm Pilot Intervention
Status: Enrolling
Updated: 6/1/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Single Wintertime Dose of Vitamin D3 to Prevent Winter Decline in Vitamin D Status in Healthy Adults
A Single Wintertime Dose of Vitamin D3 to Prevent Winter Decline in Vitamin D Concentrations in Healthy Adults: A Pilot Study
Status: Enrolling
Updated:  6/2/2016
Emory University Campus
mi
from
Atlanta, GA
A Single Wintertime Dose of Vitamin D3 to Prevent Winter Decline in Vitamin D Status in Healthy Adults
A Single Wintertime Dose of Vitamin D3 to Prevent Winter Decline in Vitamin D Concentrations in Healthy Adults: A Pilot Study
Status: Enrolling
Updated: 6/2/2016
Emory University Campus
mi
from
Atlanta, GA
Click here to add this to my saved trials
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated:  6/6/2016
Clinical Research Facility
mi
from
Stanford, CA
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated: 6/6/2016
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated:  6/6/2016
Clinical Research Facility
mi
from
New Haven, CT
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated: 6/6/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated:  6/6/2016
Clinical Research Facility
mi
from
Tampa, FL
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated: 6/6/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated:  6/6/2016
Clinical Research Facility
mi
from
Boston, MA
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated: 6/6/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated:  6/6/2016
Clinical Research Facility
mi
from
Ann Arbor, MI
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated: 6/6/2016
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated:  6/6/2016
Clinical Research Facility
mi
from
Rochester, MN
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated: 6/6/2016
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated:  6/6/2016
Clinical Research Facility
mi
from
New York, NY
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated: 6/6/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated:  6/6/2016
Clinical Research Facility
mi
from
New York, NY
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated: 6/6/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated:  6/6/2016
mi
from
Innsbruck,
AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients
A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron Emission Tomography, of AZD3241 in Subjects With Multiple System Atrophy
Status: Enrolling
Updated: 6/6/2016
mi
from
Innsbruck,
Click here to add this to my saved trials
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated:  6/7/2016
Arizona Burn Center Maricopa Medical Center
mi
from
Phoenix, AZ
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated: 6/7/2016
Arizona Burn Center Maricopa Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated:  6/7/2016
MedStar Washington Hospital Center
mi
from
Washington,
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated: 6/7/2016
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated:  6/7/2016
North Carolina Jaycee Burn Center
mi
from
Chapel Hill, NC
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated: 6/7/2016
North Carolina Jaycee Burn Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated:  6/7/2016
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated: 6/7/2016
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated:  6/7/2016
University of Tennessee Health Science Center
mi
from
Memphis, TN
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated: 6/7/2016
University of Tennessee Health Science Center
mi
from
Memphis, TN
Click here to add this to my saved trials
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated:  6/7/2016
Tampa General Hospital
mi
from
Tampa, FL
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated: 6/7/2016
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated:  6/7/2016
USAISR - US Army Institute of Surgical Research
mi
from
Fort Sam Houston, TX
ReCell® Combined With Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
Status: Enrolling
Updated: 6/7/2016
USAISR - US Army Institute of Surgical Research
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated:  6/14/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated: 6/14/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated:  6/14/2016
University of Alabama at Birmingham Cancer Center
mi
from
Birmingham, AL
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated: 6/14/2016
University of Alabama at Birmingham Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated:  6/14/2016
Howard University Hospital
mi
from
Washington,
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated: 6/14/2016
Howard University Hospital
mi
from
Washington,
Click here to add this to my saved trials
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated:  6/14/2016
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated: 6/14/2016
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated:  6/14/2016
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated: 6/14/2016
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated:  6/14/2016
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated: 6/14/2016
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated:  6/14/2016
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated: 6/14/2016
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated:  6/14/2016
The Mayo Clinic
mi
from
Rochester, MN
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated: 6/14/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated:  6/14/2016
Washington University School of Medicine
mi
from
Saint Louis, MO
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas
Status: Enrolling
Updated: 6/14/2016
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
Status: Enrolling
Updated:  6/14/2016
Cleveland Clinic - Main Campus Only
mi
from
Cleveland, OH
Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
Status: Enrolling
Updated: 6/14/2016
Cleveland Clinic - Main Campus Only
mi
from
Cleveland, OH
Click here to add this to my saved trials
Radiographic Contrast To Differentiate Cavitated From Non-cavitated Tooth Decay
Radiographic Contrast To Differentiate Cavitated From Non-cavitated Tooth Decay
Status: Enrolling
Updated:  6/15/2016
Creighton University School of Dentistry
mi
from
Omaha, NE
Radiographic Contrast To Differentiate Cavitated From Non-cavitated Tooth Decay
Radiographic Contrast To Differentiate Cavitated From Non-cavitated Tooth Decay
Status: Enrolling
Updated: 6/15/2016
Creighton University School of Dentistry
mi
from
Omaha, NE
Click here to add this to my saved trials
Randomized Controlled Trial to Assess Efficacy of Melatonin for Children During Burn Rehabilitation
Randomized Controlled Trial to Assess Efficacy of Melatonin for Children During Burn Rehabilitation
Status: Enrolling
Updated:  6/27/2016
Shriners Hospital for Children
mi
from
Cincinnati, OH
Randomized Controlled Trial to Assess Efficacy of Melatonin for Children During Burn Rehabilitation
Randomized Controlled Trial to Assess Efficacy of Melatonin for Children During Burn Rehabilitation
Status: Enrolling
Updated: 6/27/2016
Shriners Hospital for Children
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT)
Safety and Efficacy of EXE844 Otic Suspension in the Treatment of Otitis Media at Time of Tympanostomy Tube Insertion
Status: Enrolling
Updated:  6/27/2016
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT)
Safety and Efficacy of EXE844 Otic Suspension in the Treatment of Otitis Media at Time of Tympanostomy Tube Insertion
Status: Enrolling
Updated: 6/27/2016
Contact Alcon Call Center for Trial Locations
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
Pilot Study of Ranibizumab (Lucentis) for Neurofibromas Associated With Neurofibromatosis 1
Status: Enrolling
Updated:  7/6/2016
Massachusetts General Hospital
mi
from
Boston, MA
Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
Pilot Study of Ranibizumab (Lucentis) for Neurofibromas Associated With Neurofibromatosis 1
Status: Enrolling
Updated: 7/6/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated:  7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated: 7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated:  7/12/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated: 7/12/2016
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated:  7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated: 7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated:  7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated: 7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated:  7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated:  7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Phase III Comparison of Oral Capsaicin Lozenge Versus Placebo Lozenge for Radiation-Induced Mucositis
Status: Enrolling
Updated: 7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials